China Wholesale Ceramide In Cosmetics Factory Suppliers - UniAPI-PBS / Polymyxin B sulfate – Uniproma

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Innovation, excellent and reliability are the core values of our firm. These principles today more than ever form the basis of our success as an internationally active mid-size corporation for Ethylhexyl Dimethyl Paba , Tan And Protect , Sunscreen For Head , We fully welcome customers from all over the world to establish stable and mutually beneficial business relationships, to have a bright future together.
China Wholesale Ceramide In Cosmetics Factory Suppliers - UniAPI-PBS / Polymyxin B sulfate – Uniproma Detail:

Product Paramete

Trade name UniAPI-PBS
CAS 1405-20-5
Product Name Polymyxin B sulfate
Appearance White or almost white powder
Solubility Water soluble
Application Medicine
Assay The sum of polymyxin B1, B2, B3 and B1-I: 80.0% minPolymyxin B3: 6.0% maxPolymyxin B1-I: 15.0% max
Package 1kg net per aluminum can
Shelf life 2 years
Storage Store in cool and dry place, away from light. 2~8℃ for storage.
Chemical Structure

Application

Polyxin B sulfate is a cationic surfactant antibiotic, a mixture of polyxin B1 and B2, which can improve the permeability of cell membrane. Almost odourless. Sensitive to light. Hygroscopic. Soluble in water, slightly soluble in ethanol.

Clinical effect

Its antibacterial spectrum and clinical application are similar to polymyxin e. it has inhibitory or bactericidal effects on Gram-negative bacteria, such as Escherichia coli, Pseudomonas aeruginosa, paraescherichia coli, Klebsiella pneumoniae, acidophilus, pertussis and dysentery. Clinically, it is mainly used for infection caused by sensitive bacteria, urinary system infection caused by Pseudomonas aeruginosa, eye, trachea, meningitis, sepsis, burn infection, skin and mucous membrane infection, etc

pharmacological action

It has antibacterial effect on Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Haemophilus, enterobacter, Salmonella, Shigella, pertussis, pasteurella and Vibrio. Proteus, Neisseria, Serratia, pruvidens, Gram-positive bacteria and obligate anaerobes were not sensitive to these drugs. There was cross resistance between this drug and polymyxin E, but there was no cross resistance between this drug and other antibiotics.

It is mainly used for wound, urinary tract, eye, ear, trachea infection caused by Pseudomonas aeruginosa and other Pseudomonas. It can also be used for sepsis and peritonitis.

 


Product detail pictures:

China Wholesale Ceramide In Cosmetics Factory Suppliers - UniAPI-PBS / Polymyxin B sulfate  – Uniproma detail pictures


Related Product Guide:

We support our purchasers with ideal high-quality merchandise and significant level company. Becoming the specialist manufacturer in this sector, we now have received loaded practical encounter in producing and managing for China Wholesale Ceramide In Cosmetics Factory Suppliers - UniAPI-PBS / Polymyxin B sulfate – Uniproma, The product will supply to all over the world, such as: European, India, Bangladesh, With the development and enlargement of mass clients abroad, now we have set up cooperative relationships with many major brands. We have our own factory and also have many reliable and well-cooperated factories in the field. Adhering to the "quality first, customer first, We are provideing high-quality, low-cost products and first-class service to customers. We sincerely hope to establish business relationship with customers from all over the world on the basis of quality, mutually benefit. We welcome OEM projects and designs.
  • It can be said that this is a best producer we encountered in China in this industry, we feel lucky to work with so excellent manufacturer.
    5 Stars By Wendy from Bulgaria - 2018.09.21 11:44
    This company has the idea of "better quality, lower processing costs, prices are more reasonable", so they have competitive product quality and price, that's the main reason we chose to cooperate.
    5 Stars By Austin Helman from Berlin - 2017.03.07 13:42